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Enteroaggregative E. coli (EAEC) are a major cause of diarrhoea worldwide. Due to their heterogeneity 
and carriage in healthy individuals, identification of diagnostic virulence markers for pathogenic strains 
has been difficult. In this study, we have determined phenotypic and genotypic differences between 
EAEC strains of sequence types (STs) epidemiologically associated with asymptomatic carriage (ST31) 
and diarrhoeal disease (ST40). ST40 strains demonstrated significantly enhanced intestinal adherence, 
biofilm formation, and pro-inflammatory interleukin-8 secretion compared with ST31 isolates. This 
was independent of whether strains were derived from diarrhoea patients or healthy controls. Whole 
genome sequencing revealed differences in putative virulence genes encoding aggregative adherence 
fimbriae, E. coli common pilus, flagellin and EAEC heat-stable enterotoxin 1. Our results indicate that 
ST40 strains have a higher intrinsic potential of human pathogenesis due to a specific combination 
of virulence-related factors which promote host cell colonization and inflammation. These findings 
may contribute to the development of genotypic and/or phenotypic markers for EAEC strains of high 
virulence.
Enteroaggregative E. coli (EAEC) are emerging pathogens most commonly associated with acute and persistent 
paediatric diarrhoea and growth retardation in developing nations1. In addition, EAEC are a major cause of 
acute diarrhoea in travellers to developing countries2 and persistent enteric infection in HIV/AIDS patients3. 
Notably, a large outbreak in Germany in 2011 was caused by a hybrid O104:H4 EAEC strain which carried the 
Shiga toxin gene from enterohaemorrhagic E. coli and resulted in over 4,300 cases of diarrhoea, 900 hospitalisa-
tions and 50 deaths4. EAEC are a heterogenous group and have been traditionally defined by their characteristic 
“stacked brick”-like aggregative adherence (AA) to HEp-2 cells5. Pathogenesis involves adherence to the intestinal 
epithelium, stimulation of mucus secretion, biofilm formation, cytotoxic damage and mucosal inflammation. 
Several putative virulence factors involved in these processes have been identified6,7. These include the aggregative 
adherence fimbriae (AAF) of which five major variants have been described so far (AAF/I to AAF/V)8–12. AAF 
are encoded on the pAA virulence plasmid which also contains the major transcriptional regulator AggR and the 
surface protein dispersin which contributes to AAF dispersal13–15. Notably, alternative adhesins such as the E. coli 
common pilus (ECP) can mediate aggregative adherence, particularly in the absence of AAF16. Further potential 
virulence factors of EAEC include the cytotoxins Pet, enteroaggregative Escherichia coli heat-stable enterotoxin 1 
(EAST-1), and haemolysin E (HlyE) which promote epithelial damage and intestinal colonization6. In addition, 
the serine protease Pic exhibits mucinolytic activity and also stimulates intestinal mucus secretion17,18. Despite 
the identification of multiple putative EAEC virulence candidates, not all EAEC strains harbouring these factors 
cause human disease, and genotypic studies have failed to consistently associate a single gene or combination of 
genes with EAEC virulence6,19. To determine if certain EAEC lineages were more strongly associated with disease 
than others, Chattaway and colleagues analysed 564 EAEC isolates from three case-control studies in Bangladesh, 
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Nigeria and the UK by Multi Locus Sequence Typing (MLST)20. Of the 17 sequence types (STs) identified, ST40 
and ST31 were significantly associated with disease and asymptomatic carriage, respectively. Here, we investi-
gated if the association of EAEC ST40 with disease was linked to specific virulence phenotypes in vitro. To this 
aim, we selected eight strains each of ST40 (diarrhoea-associated) and ST31 (carriage-associated) and determined 
aggregative adherence (AA) to intestinal epithelium, interaction with mucus, biofilm formation, cytotoxicity and 
stimulation of an inflammatory response. In addition, all strains were genome-sequenced, and bioinformatic 
analysis was used to identify putative virulence genes associated with disease potential.
Results
ST40 strains adhere better to human colonic epithelium than ST31 isolates. For this study, eight 
strains from each ST31 and ST40 were selected including isolates from diarrhoea patients and healthy controls. 
The EAEC prototype strain 042 was included as positive control (Table S1). As many of the ST31 and ST40 
strains were classified as EAEC by PCR probes only, all isolates were first tested for AA on Hep-2 cells which is 
the current gold-standard for the definition of the EAEC pathotype5. As shown in Fig. 1 (images shown for four 
strains of each ST only), all strains adhered in stacked-brick like aggregates to the cells and underlying coverslips. 
We further investigated adherence of the EAEC strains to human colonic epithelium in vitro and ex vivo. On 
confluent T84 colon carcinoma cells, adhesion of ST40 strains was significantly higher compared to that of ST31 
isolates (Fig. 2A). In contrast, no differences in the number of cell-bound bacteria between isolates from cases and 
controls were detected. Quantification of EAEC growth in cell culture medium alone demonstrated replication 
of all strains during the 2 h incubation period which did not differ significantly between strains of ST31 and ST40 
(Fig. S1). Similar results to those on T84 cells were obtained using IVOC of human colonic biopsies, although 
colonization levels of ST31 strains were more variable compared to those in cell culture. While all EAEC strains 
demonstrated AA to colonic tissue, colonization was significantly higher in EAEC strains of ST40 than ST31 
(Fig. 2B,C). In addition, ST31 strains from controls adhered significantly better than ST31 isolates from patients 
with diarrhoea (Fig. 2B, P < 0.01).
Growth in mucus-containing medium is similar in ST31 and ST40 strains. Previous studies have 
suggested that utilisation of mucin as a nutrient source by EAEC might provide an advantage for intestinal colo-
nization21. We therefore determined the growth of EAEC ST31 and ST40 strains in minimal M9 medium with or 
without porcine gastric mucin. Growth in M9 alone was low for all strains tested with significantly higher optical 
densities of ST31 versus ST40 strains (p = 0.017, Fig. 3A). However, addition of mucin enhanced growth of ST31 
and ST40 strains to similar levels (Fig. 3A). No significant differences were detected in strains from cases and 
controls.
Infection with EAEC ST31 and ST40 strains does not affect mucin levels in LS174T cells. Mucus 
secretion is a major feature in EAEC-mediated diarrhoea. To investigate the influence of EAEC infection on cellu-
lar mucus levels, mucin-producing LS174T cells were infected with EAEC, and production of the major secreted 
intestinal mucin MUC2 was determined by immunofluorescence staining (Fig. 3B). Subsequent densitometric 
analysis did not reveal any significant effect of EAEC infection on MUC2 production for any of the ST strains 
tested (Fig. 3C).
EAEC ST40 strains form enhanced biofilms compared to ST31 isolates. EAEC infection is 
associated with the formation of thick aggregating biofilms in the mucus layer and at the epithelial surface 
which impedes antibiotic penetration and efficacy of treatment22,23. Interestingly, ST40 isolates demonstrated 
Figure 1. Aggregative adherence of EAEC to HEp-2 cells. Cells were infected with EAEC or left non-infected 
(NI) for 3 h, and adherent bacteria were visualised by Giemsa staining. Shown are representative images of two 
experiments performed in duplicate. Bar = 5 μm.
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significantly enhanced biofilm formation on plastic surfaces compared to ST31 strains whilst reference strain 042 
demonstrated the highest degree of biofilm formation (Figs. 4A and S2). No difference in biofilm intensity was 
detected between strains isolated from cases of diarrhoea and healthy controls within each ST.
EAEC ST31 and ST40 isolates exhibit similar cytotoxicity in T84 cells. A prominent feature of 
EAEC pathogenesis is the release of cytotoxins which promote epithelial cell death and mucosal damage6,24. To 
determine the cytotoxic effect of ST31 and ST40 isolates on T84 cells, infections were performed for 8 h, and cell 
death was quantified by Trypan Blue stain. Infection with neither EAEC strain resulted in host cell detachment, 
and monolayer integrity after staining was confirmed by microscopy (Fig. S3, representative images shown for 
042 and the highly cytotoxic strains E104946 and 221654). As shown in Fig. 4B, variable levels of cytotoxicity were 
observed, particularly among ST31 strains. However, there was no significant difference between the overall levels 
of T84 cell death caused by ST31 versus ST40 strains or between strains derived from cases or controls.
Figure 2. (A) Adhesion of EAEC ST strains to T84 cells after 2 h of infection. Adherent bacteria were quantified 
by determining colony-forming units (CFU) in cell lysates. Results represent the mean ± standard error of 
the mean (SE) from three independent experiments in duplicate. Data from groups of ST31 and ST40 isolates 
were analysed using Student’s unpaired t-test. P*** < 0.001. (B) Colonization of colonic biopsies after 7 h of 
incubation. Samples were evaluated by scanning electron microscopy, and colonization was ranked according 
to the size and frequency of bacterial aggregates as described in methods. Results from three independent 
experiments in duplicate are shown as box plots with medians. Significance was calculated using the non-
parametric Mann-Whitney test. P*** < 0.001. (C) Scanning electron micrographs of colonic biopsies infected 
with EAEC or left non-infected (NI). Shown are representative images of three experiments performed in 
duplicate. Bar = 10 μm (EAEC), 50 μm (NI).
4Scientific RepoRtS |         (2020) 10:7475  | https://doi.org/10.1038/s41598-020-64424-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
ST40 isolates induce higher levels of IL-8 secretion from T84 cells. To evaluate the inflammatory 
response associated with infection, confluent T84 cells were incubated with EAEC for 3 h. IL-8 concentrations 
in the supernatant were quantified by ELISA after an additional incubation of 20 h in gentamicin-containing 
Figure 3. (A) Growth of EAEC ST strains in M9 medium with (+PGM) or without 0.5% porcine gastric mucin 
(-PGM) for 8 h was determined by optical density (OD600). Strains from cases or controls are underlined in 
red and green, respectively. Results represent the mean ± SE from three independent experiments. Data from 
groups of ST31 and ST40 isolates were analysed using Student’s unpaired t-test. (B) Influence of EAEC infection 
on mucin production by LS174T cells. Cells were infected with EAEC strains for 4 h or left non-infected (NI). 
Mucus production was visualised by immunofluorescence staining for MUC2 (green), and EAEC were stained 
in red. Shown are representative images of NI samples and cells infected with E104931 (EAEC). Bar = 50 
μm. (C) MUC2 staining was quantified by integrated density. Results represent the mean ± SE from at least 
four independent experiments in duplicate. Data from groups of ST31 and ST40 isolates were analysed using 
Student’s unpaired t-test.
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medium, which allows host cell protein synthesis and secretion but prevents bacterial overgrowth. Trypan Blue 
staining of cell monolayers at the end of incubation confirmed that no significant cell death was caused by any of 
the strains compared to non-infected controls (data not shown). As demonstrated in Fig. 4C, infection with ST40 
isolates resulted in significantly higher levels of IL-8 secretion compared to ST31 strains. In contrast, no associa-
tion was observed between IL-8 concentrations and whether strains originated from cases or controls
ST31 and 40 strains exhibit differences in putative virulence genes. To determine genomic differ-
ences between the two STs which could explain their different phenotypic properties, whole genome sequencing 
was performed for all strains. Firstly, we determined the ST of all strains from the sequence reads and confirmed 
their previously established MLST20. In addition, short read sequence typing was used to predict the serotype of 
each strain in silico which had only been partially established by serum agglutination testing before (Table 1). 
While ST31 strains belonged to serogroups O130:H27 or O15:H18, ST40 strains mainly displayed O111:H21. 
There was no considerable difference between serotypes of case or control strains, although more isolates 
need to be analysed to confirm this. Sequence analysis for EAEC-associated putative virulence genes obtained 
from GenBank (aggR FN554767.1, pic FN554766.1, aap FN554767.1, astA FN554767.1, hlyE FN554766.1, pet 
FN554767.1, ecpA FN554766.1, aggA U12894.1, aafA FN554767.1, agg3A AF411067.1, hdaA EU637023.1, and 
aaf5A AB571097.1) demonstrated that astA (EAST-1 toxin) was present in all ST40 but lacking in ST31 isolates 
(Table 2). Furthermore, ecpA (E. coli common pilus) was strongly associated with ST40 and encoded by only 
a quarter of ST31 strains. ST31 and 40 strains also differed in AAF type with ST40 strains harbouring aaf5A 
Figure 4. (A) Biofilm formation of EAEC ST strains. Bacteria were incubated in 96-well plates for 48 h, stained 
with crystal violet and absorbance was quantified (OD595). (B) Cytotoxicity of EAEC infection. Death of T84 
cells was quantified by Trypan Blue staining after 8 h of infection. Non-infected cells (NI) were included as 
controls. (C) Secretion of interleukin-8 (IL-8) by T84 cells infected with EAEC. IL-8 levels in supernatants 
were quantified by ELISA after 24 h of incubation. Results represent the mean ± SE from three independent 
experiments in duplicate. Data from groups of ST31 and ST40 isolates were analysed using Student’s unpaired 
t-test. P* < 0.05, P*** < 0.001.
ST Straina Serum agglutination In silico typing
31 042 O44:H18 O44:H18
31 E099975 O15:H18 O15:H18
31 E104931 UD O130:H27
31 E104940 O130:H27 O130:H27
31 E104969 O130:H25 O130:H27
31 E104946 UD O15:H18
31 E104967 UD O15:H18
31 E103617 O130:H27 O130:H27
31 E107526 UD O130:H27
40 E107759 UD O127:H21
40 E109907 O111ab:H- O111:H21
40 1091 O111ac:H11 O111:H21
40 1337 O111ac:H11 O111:H21
40 146052 0154:H21 O25:H21
40 153145 O111:H21 O111:H21
40 221654 O111:H21 O111:H21
40 232736 O111:H21 O111:H21
Table 1. EAEC serotype determination. aIsolates from cases (bold) and controls. UD = undetermined.
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(AAF/V) and ST31 O130 and O15 strains expressing aggA (AAF/I) and agg3A (AAF/III), respectively (Table 2). 
While a coverage threshold of 90% was applied for all read alignments, this was reduced to 80% for aggA. In con-
trast to differences between STs, virulence gene profiles were similar in isolates from cases or controls within each 
ST. Further differences between ST31 and ST40 were identified using the Virulence Factors of Bacterial Pathogens 
database (VFDB), and genes found in specific STs only are listed in Table 3. While VFDB analysis confirmed the 
association of AAF/I and AAF/III with ST31 and the prevalence of EAST1 in ST40 strains, other ST40-specific 
fimbriae and adhesins (cfa, ehaA, stg, ycb) were identified which may contribute to the enhanced host cell binding 
of this ST. In addition to the 16 strains phenotypically characterised in this study, a further 31 ST31 and 8 ST40 
clinical EAEC isolates from PHE were sequenced and analysed. Similar to our previous results, O130:H27 was 
the predominant serotype in ST31 strains (16 out of 31 strains, Table S2). In addition, three strains were identified 
as O25:H2, while two isolates belonged to serotype O15:H18 identified in ST31 previously. For ST40, half of the 
strains encoded O111:H21 (Table S2). Analysis of all ST31 and ST40 whole genome sequences for EAEC-specific 
virulence gene alleles obtained from the VFDB confirmed the prevalence of astA in ST40 (88%) versus ST31 
strains (26%, Fig. 5). In addition, all but one ST40 strain harboured ecpA, while this gene was present in only 49% 
of ST31 isolates. Interestingly, one particular allele (ecpA_CVF625_VFG034419) was detected in 81% of ST40 
versus only 5% of ST31 strains. With regards to AAF, aaf5A was the prominent variant in ST40 (75%), whereas 
more than half of ST31 strains did not harbour any AAF type, and one third were positive for aggA. Another 
interesting finding emerging from the VFDB analysis was that although all ST31 and ST40 isolates possessed a 
gene for haemolysin E (hlyE), different alleles dominated in ST31 (VFG036058) and ST40 strains (VFG036061, 
Fig. 5).
Discussion
Clinical pathology and laboratory research suggest that EAEC pathogenesis involves adherence to the intesti-
nal mucosa, mucus secretion, biofilm formation, cytotoxic damage and mucosal inflammation due to cytokine 
release25. Importantly, the majority of EAEC in vitro and in vivo studies have been conducted using prototype 
strain 042 which we have included as positive control in all phenotypic assays. Although 042 belongs to ST31, 
it does not share any characteristics with the other ST31 strains investigated in this study. This may be due to 
differences in origin (Peru versus UK) or changes in genotype/phenotype during prolonged laboratory passage 
and underlines the heterogeneity of the EAEC pathotype and necessity to open up research to a wider range of 
EAEC isolates.
Adhesion to the intestinal mucosa is the first step in EAEC colonization of the human gut22,26, and increased 
adherence of ST40 versus ST31 strains could explain the higher association of this ST with diarrhoeal disease. 
While AA to cervix-derived HEp-2/HeLa cells is supported by all five variants of AAFs8–12, a role for binding to 
human intestinal epithelium has only been demonstrated for AAF/I and AAF/II8,27 while the relevance of AAF/
III-V remains unknown. Genotypic analysis showed that the ST40 strains investigated in our study possessed 
the fimbrial variant AAF/V whereas ST31 strains harboured the gene for AAF/I or AAF/III. Notably, alignment 
of aggA (encoding the major pilin subunit of AAF/I) to the query sequence of EAEC strain 17-2 showed less 
than 90% identity suggesting the presence of a different fimbrial variant. However, high variability with up to 
83% identity has been previously reported for the major pilin subunit Agg5A12. Furthermore, the presence of 
the AAF/I accessory genes aggB-D in respective ST31 strains supports the identification of AAF/I. Interestingly, 
expression of AAF/V in E. coli HB101 resulted in higher adhesion to HEp-2 cells compared to expression of AAF/
Straina Serotype aggRb pic aap astA hlyE pet ecpA
aggA 
(AAF/I)c
aafA 
(AAF/II)
agg3A 
(AAF/III)
hdaA 
(AAF/IV)
aaf5A 
(AAF/V)
ST31
042 O44:H18 + + + + + + + +
E103617 O130:H27 + + + + + +
E104946 O15:H18 + + + + +
E104967 O15:H18 + + + + +
E107526 O?:H27 + + + +
E099975 O15:H18 + + + + +
E104931 O130:H27 + + + + + +
E104940 O130:H27 + + + + +
E104969 O130:H27 + + + + +
ST40
1091 O111:H21 + + + + + + +
1337 O111:H21 + + + + + + +
146052 O?:H21 + + + + +
153145 O111:H21 + + + + + + +
221654 O111:H21 + + + + + + +
232736 O111:H21 + + + + + + +
E107759 O127:H21 + + + + + + +
E109907 O111:H21 + + + + + + +
Table 2. Detection of selected EAEC virulence genes in whole genome sequences of ST strains by using 
the Short Read Sequence Typing 2 tool (SRST2). aIsolates from cases (bold) and controls, bPresence of gene 
indicated by +, cCoverage threshold below 90% identity.
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III12 suggesting different binding affinities of AAF variants to epithelial cell receptors. Previous studies have iden-
tified the mucin glycoprotein MUC1, intermediate filament-associated cytokeratin 8, and the extracellular matrix 
proteins fibronectin, laminin, and type IV collagen as cellular binding partners for AAF/II28–30. While AAF/I and 
AAF/II bind to fibronectin by electrostatic interactions, AAF/V does not recognize fibronectin or other extracel-
lular matrix proteins31,32. This might indicate a preference for more accessible host receptors on the apical cell sur-
face (e.g. MUC1) which facilitate initial binding to the intestinal epithelium. Notably, more than half of the ST31 
strains sequenced in our study did not harbour any AAF variant, and it remains to be investigated if this contrib-
utes to the lower disease potential of this clonal complex. Apart from AAF, other adhesins have been implicated 
in EAEC - host cell binding. A previous study characterising 130 EAEC strains of diverse origin reported that 
only 3.1% and 5.4% of isolates were positive for AAF/I and AAF/II genes, respectively, while 96% contained the 
ECP structural gene ecpA, and 63% of those produced ECP when adhering to HEp-2 cells16. In addition, an ecpA 
deletion mutant in enterohaemorrhagic E. coli was deficient in HEp-2 cell binding. Therefore, the prevalence of 
ecpA and particularly, its specific allele VFG034419, in ST40 versus ST31 strains might suggest a role of ECP in 
adherence to the gut epithelium. In addition to AAF/V and ECP, other ST40-specific adhesins were identified 
which include CFA/I fimbriae mediating adherence of enterotoxigenic E. coli to human intestinal mucosa1, Stg 
fimbriae promoting epithelial attachment of Salmonella Typhi33, and the type V secretion system autotransporter 
EhaA involved in enterohaemorrhagic E. coli aggregation and adhesion to bovine rectal epithelial cells34.
In addition to epithelial adherence, EAEC interaction with mucus appears to play an important role in 
infection as evidenced by the presence of mucus in stools of diarrhoeal patients and the thick bacterial bio-
films observed in the intestinal mucus layer6. Previous studies have shown that the serine protease Pic exhibits 
mucinolytic activity and enables EAEC growth in mouse caecal mucus and minimal medium containing bovine 
submaxillary mucin17,21. This agrees with our results demonstrating that both EAEC ST31 and ST40 harbour pic 
and can use porcine gastric mucin as a nutrient source. In our previous studies, we have demonstrated that the 
metalloprotease StcE degrades MUC2 and thereby facilitates adherence of enterohaemorrhagic E. coli to human 
LS174T cells and colonic biopsy samples35. However, we did not detect any influence of EAEC infection on MUC2 
production by LS174T cells in this study. In addition to its mucinolytic activity, Pic also acts as a secretagogue and 
stimulates mucus secretion in rat ileal loops18. As this is mediated by an increase in goblet cell numbers rather 
than increased mucin expression by existing goblet cells, an in vivo system would be required to investigate this 
effect.
Mucus secretion facilitates biofilm formation on intestinal mucosa which is a characteristic virulence feature 
of EAEC24,36. Previous studies have shown that AAF/I-V are required for biofilm formation in several EAEC 
strains including prototype strain 0429,12,37. In addition, there may be accessory factors modulating biofilm com-
position and density as the gene shf has been shown to be required for the establishment of firm biofilms by EAEC 
04238. Interestingly, type 1 fimbriae and flagella which have been implicated in biofilm formation by uropatho-
genic E. coli and E. coli K-1239,40, did not affect aggregation of EAEC 04237. Our results demonstrated increased 
Gene
Present in all 
strains of Function
EC042_4532 ST31 Putative type VI secretion protein
air/eaeX ST31
Enteroaggregative immunoglobulin-repeat 
protein with predicted homology to intimin from 
enteropathogenic E. coli
aslA ST31 Putative Ser-type periplasmic non-aryl sulfatase
chuA, S-Y ST31 Haem utilisation operon
ehaB ST31 Autotransporter linked to adhesion and biofilm formation
kpsD ST31 Polysialic acid transport protein
pkgA ST31 Putative type III secretion effector
sitA-D ST31 Iron/manganese transport operon
aggB-D ST31 (O130) AAF/I accessory genes
gspC-M ST31 (O130) & ST40 Cryptic type 2 secretion system
agg3A ST31 (O15:H18) AAF/III structural subunit
hlyA-D ST31 (O15:H18) Alpha-haemolysin
papA-K, X ST31 (O15:H18) P pilin operon
agg3 B-D ST31 (O15:H18) & ST40 AAF/III accessory genes
astA ST40 EAST-1 toxin
cfaA-D ST40 CS1 fimbrial operon
ehaA ST40 Autotransporter linked to adhesion and biofilm formation
stgC,D ST40 Part of Stg fimbrial operon
ycbF,R-V ST40 Putative chaperone-usher fimbrial operon
Table 3. Prevalence of bacterial virulence genes in ST31 and ST40 strains as determined from whole genome 
sequences using Virulence Factor Database.
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biofilm formation by EAEC ST40 versus ST31 strains, although variation within ST groups was more pronounced 
compared to that observed in adherence assays. Similar to cell adhesion, it could be argued that biofilm formation 
might be dependent on AAF variant, with AAF/V present in ST40 promoting stronger aggregation than AAF/I 
or AAF/III in ST31. However, this does not apply to ST31 strain E104931 and ST40 strain 221654 which formed 
stronger and weaker aggregates than the other ST31 and ST40 isolates, respectively. Therefore, additional factors 
to AAF must play a role in biofilm formation by these EAEC strains.
Cytotoxicity is another prominent feature of EAEC pathogenesis and has been demonstrated in human intes-
tinal biopsies and T84 cells24. Previous studies in our laboratory have shown that EAEC binding to T84 cells 
induces gene expression of the toxins EAST-1, HlyE and Pet suggesting a role in EAEC virulence41. As Pet is 
absent in all ST31 and ST40 strains characterised in this study, and EAST-1 is expressed in ST40 isolates only, 
these two toxins are unlikely the cause for the cytotoxic effects observed in T84 monolayers infected with EAEC 
ST31 and ST40 isolates. In contrast, the pore-forming toxin HlyE is encoded by both ST31 and ST40 strains, 
although different alleles predominate in each ST, and the contribution of HlyE to epithelial damage warrants 
further investigation.
Mucosal inflammation also contributes to EAEC pathogenesis, and elevated levels of the pro-inflammatory 
cytokines IL‐1β and IL‐8 have been detected in stool samples from patients with EAEC diarrhoea42,43. Several 
EAEC proteins have been identified which promote secretion of the neutrophil chemoattractant IL-8 in vitro, and 
varying results have been obtained depending on the cell line used and its differentiation status. While the IL-8 
response in non-polarized T84 cells infected with EAEC 042 was mainly dependent on flagellin, AafB (minor pilin 
protein of AAF/II) also contributed to IL-8 secretion by polarized T84 epithelia44. Stimulation of IL-8 secretion 
by flagella and AafB was further confirmed in HEp-2 and Caco-2 cells45,46. Another study showed that deletion of 
the gene for AafA (major pilin protein of AAF/II) severely reduced IL-8 driven neutrophil transmigration across 
042-infected T84 epithelia, whilst deletion of the genes encoding AafB or flagellin did not have any effect47. In 
addition, expression of AAF/I, AAF/III, or AAF/IV induced neutrophil transmigration by other EAEC prototype 
strains, and the dependency of EAEC-induced inflammation on AAF was confirmed in human intestinal xeno-
graft mice47. Our studies demonstrated higher IL-8 secretion by T84 cells infected with ST40 versus ST31 strains 
which might be caused by differences in AAF variant and/or flagellin type. While ST40 strains expressed AAF/V 
and H21, ST31 strains encoded either AAF/I and H27 or AAF/III and H18. Differences in pro-inflammatory 
responses to AAF variants have been demonstrated in human intestinal biopsies with higher IL-8 secretion 
in tissues infected with AAF/II- versus AAF/I- or AAF/III-expressing EAEC strains48. Furthermore, purified 
AAF/II induced greater neutrophil transmigration across T84 cells than AAF/I when applied with E. coli K-1228. 
Similarly, uropathogenic E. coli expressing H4 flagella induced higher levels of IL-10 secretion compared to 
isogenic mutants harbouring H1 and H7 alleles49.
In addition to differences in ECP, AAF and flagellin alleles, all ST40 isolates in our phenotypic study contained 
astA which was absent in ST31 strains. This gene encodes the low-molecular-weight EAEC heat-stable entero-
toxin 1 (EAST1) which shares significant homology with the heat-stable enterotoxin of enterotoxigenic E. coli50 
and stimulates anion secretion by T84 epithelia51. While astA was significantly associated with infant diarrhoea in 
Brazil versus asymptomatic controls52, the gene was commonly detected in both clinical and non-clinical EAEC 
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Figure 5. Presence of EAEC virulence-related gene alleles in whole genome sequences of 39 ST31 and 16 
ST40 isolates. Strains characterised phenotypically in this study are highlighted in red. Several alleles present 
in the VFDB were detected for aggR, pic, hlyE, ecpA, and agg3A, and the presence of each allele is indicated by 
a blue box. Gene presence was determined by SRST2, except for aggA where only a partial read alignment was 
indicated. In this case, BLAST analysis was used which showed an average nucleotide identity of 86.5%.
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strains in China53. Therefore, its relevance as a marker for pathogenic EAEC remains uncertain, and future studies 
are needed to further establish the role of EAST1 in intestinal disease.
While we established a correlation between certain virulence traits and genes with ST31 and ST40 strains, no 
difference was observed between isolates from diarrhoea cases and asymptomatic carriers within each group. 
Notably, only two of the investigated ST40 isolates were derived from healthy controls, so further confirmation is 
required for this ST. Nevertheless, the lack of correlation between virulence trait and strain origin might be due 
to differences in host susceptibility which can be influenced by genetic and environmental factors and represent 
a considerable confounding factor in case-control association studies. Single nucleotide polymorphisms in the 
promoter region of IL-8 and CD14 and the lactoferrin gene have been linked to increased susceptibility to EAEC 
infection54–56. Another predisposing factor appears to be co-infection with other enteropathogens which is con-
siderably higher in EAEC-positive cases than in asymptomatic controls57.
Taken together, our studies suggest that EAEC ST40 strains have a higher intrinsic potential to cause 
enteric disease due to their enhanced ability to bind to human colonic epithelium, form biofilms and induce 
pro-inflammatory IL-8 secretion. Differences in AAF and flagellin alleles and/or the presence of EAST1 and ECP 
might represent the underlying cause for these phenotypes. Future studies will ascertain the suitability of these 
genotypic and phenotypic markers for identification of highly pathogenic EAEC which will improve diagnosis 
of diarrhoea. In addition, our findings in conjunction with previous data45 implicate mucosal adherence as an 
efficient target for future antimicrobial and vaccine strategies against EAEC infection.
Methods
Bacterial culture and identification. All EAEC strains used in this study are listed in Table S1 and S2. 
EAEC were defined by aat gene/CVD432 probe reaction, presence of aggR or aggregative adherence phenotype. 
For all experiments, strains were grown standing overnight in Lysogeny broth (LB Lennox) at 37 °C.
Cell culture
Human epithelial HEp-2 cells (ECACC 86030501) and LS174T colon adenocarcinoma cells (ECACC 87060401) 
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma) with 4 mM L-glutamine, 1% non-essential 
amino acids and 10% foetal bovine serum (FBS, Sigma). T84 colon carcinoma cells (ECACC 88021101) were 
maintained in DMEM/F-12 1:1 mixture (Sigma) containing 2.5 mM L-glutamine and 10% FBS and used between 
passage 46 and 63. All cells were grown at 37 °C in a 5% CO2 atmosphere.
Aggregative adherence to HEp-2 cells. HEp-2 cells were seeded at a density of 1 × 105 cells/well into 
24-well plates containing circular coverslips and grown to 60% confluency. Cells were inoculated with 107 
CFU of EAEC and incubated at 37 °C in air/5% CO2 for 3 h. Coverslips were subsequently washed thrice with 
phosphate-buffered saline (PBS), fixed in 70% methanol for 15 min and stained with 10% Giemsa Modified 
Solution (Sigma) for 30 min. Samples were observed under brightfield with a Zeiss Axio Imager M2 Microscope.
Adherence to T84 cells. T84 cells were seeded at a density of 1.5 × 105 cells/well into 24-well plates and 
cultured for 6-8 days until fully confluent. Cells were inoculated with 107 CFU of EAEC and incubated at 37 °C in 
air/5% CO2 for 2 h. After removal of non-adherent bacteria by three washes in PBS, cells were lysed in 1% Triton 
X-100 in PBS for 10 min. Serial dilutions of cell lysates and bacterial inocula were plated on LB agar plates, and 
CFU were counted the next day.
Bacterial growth in DMEM/F-12 medium. EAEC overnight cultures adjusted to OD600 1.0 were diluted 
1:100 in DMEM/F-12 medium and dispensed into 96-well plates in 100 µl aliquots. After incubation at 37 °C for 
2 h, optical density was determined at 600 nm.
In vitro organ culture of human colonic biopsies and scanning electron microscopy. This 
study was performed with approval from the University of East Anglia Faculty of Medicine and Health Ethics 
Committee (Ref 2010/11-030). All samples were registered with the Norwich Research Park Biorepository (REC 
reference 19/BE/0089) and all research was performed in accordance with relevant guidelines and regulations. 
After obtaining informed consent, biopsy samples from the sigmoid colon were taken from adult patients under-
going routine endoscopy at the Gastroenterology Department of the Norfolk and Norwich University Hospital. 
Biopsy specimens were orientated with the mucosal surface facing upwards on a foam support and submersed in 
IVOC medium (DMEM/NCTC-135 medium (1:1), 10% newborn calf serum, 1.1 g/l sodium bicarbonate, 0.5% 
D-mannose, Sigma). Samples were inoculated with 2.5 × 107 CFU of EAEC or LB medium as negative control. 
Biopsies were incubated at 37 °C in air/ 5% CO2 for 7 h on a rocking platform with medium exchange after 4 
and 6 h to prevent bacterial overgrowth. At the end of the incubation, biopsies were washed in PBS to remove 
non-adherent bacteria and fixed with 2.5% glutaraldehyde in PBS at 4 °C overnight. Specimens were subsequently 
dehydrated in a graded acetone series, dried using tetramethylsilane (Sigma), mounted on aluminium stubs, 
sputter-coated with gold (Polaron SC7640, Quorum Technologies) and observed using a JSM 4900 LV scanning 
electron microscope (JEOL). Bacterial colonization was scored on a relative scale based on size of bacterial aggre-
gates (1 = less than 10; 2 = ca 10-100; 3 = ca 100-1,000; 4 = more than 1,000 bacteria) and frequency (1 = less 
than 10%, 2 = ca 25%, 3 = ca 50%, 4 = more than 50% bacterial coverage of biopsy surface), and both values 
were added.
Growth in mucus-containing medium. EAEC overnight cultures adjusted to OD600 1.0 were diluted 
1:100 in 200 μl M9 medium (6.8 g/l Na2HPO4, 3.0 g/l KH2PO4, 1.0 g/l NH4Cl, 0.5 g/l NaCl, 0.5 g/l glucose) with or 
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without 0.5% (w/v) porcine gastric mucin (Sigma) and added to a 96-well plate. Plates were incubated at 37 °C for 
8 h, and bacterial growth was quantified by optical density (OD600; Benchmark Plus, Bio-Rad).
Quantification of mucus production in LS174T cells by immunostaining. LS174T cells were 
seeded at a density of 1.5 × 105 cells/well on circular coverslips placed in 24-well plates and grown for 5 days. 
Cells were inoculated with 107 CFU of EAEC and incubated at 37 °C in air/5% CO2 for 4 h. Non-adherent bac-
teria were removed by three washes in PBS, and cells were fixed in ice-cold methanol/ acetone (1:1) for 4 min 
on ice. For immunofluorescence staining, cells were blocked with 0.5% (w/v) bovine serum albumin in PBS for 
20 min followed by incubation in mouse anti-MUC2 (1:250, Santa Cruz) for 60 min and detection by Alexa Flour 
488-conjugated donkey anti-mouse IgG (1:400, Life Technologies). EAEC were stained with goat anti-E. coli 
(1:400, Abcam) and Alexa Flour 568-conjugated donkey anti-goat IgG (1:400, Life Technologies). Coverslips were 
mounted in Vectashield (Vector laboratories) and examined with a Zeiss Axio Imager M2 Microscope. MUC2 
staining was quantified by integrated density using ImageJ software.
Biofilm formation. EAEC overnight cultures adjusted to OD600 1.0 were diluted 1:100 in DMEM, and 
100 µl of suspension were added to a 96-well plate. After incubation at 37 °C in air/5% CO2 for 48 h, media were 
removed, and wells were washed twice with sterile water. Bacterial biofilms at the bottom of the well were stained 
with 0.1% crystal violet (w/v) for 10 min. After removal of excess stain with two washes in water, plates were dried, 
and the crystal violet stain was solubilised in 30% acetic acid and quantified by optical density (OD595).
Cytotoxicity assay. Confluent T84 cells in 24-well plates were inoculated with 2 × 107 CFU of EAEC and 
incubated at 37 °C in air/5% CO2 for 8 h. After removal of the medium, dead cells were stained with 0.05% Trypan 
Blue for 15 min at 37 °C. Unbound dye was removed by washing with PBS, and monolayer integrity was con-
firmed by microscopy. Internalised dye was subsequently released by cell lysis in 1% SDS, and absorbance was 
determined at OD590.
Interleukin-8 secretion. T84 cells were seeded out at a density of 4 × 105 cells/well into 12-well plates and 
grown for 6 days until fully confluent. Cells were infected with 1.5 × 107 CFU and incubated for 3 h at 37 °C in 
air/5% CO2. After removal of non-adherent bacteria, fresh medium containing 50 μg/ml gentamicin (Sigma) was 
added, and cells were incubated for another 20 h. IL-8 in supernatants was determined by ELISA (Peprotech) 
according to the manufacturer’s instructions. In addition, cytotoxicity was quantified by Trypan Blue staining as 
described above.
Genome sequencing. Extracted bacterial DNA was converted into Nextera XT libraries according to the 
library preparation guide (Illumina) for sequencing on an Illumina NextSeq platform. Libraries were quanti-
fied using HS dsDNA Qubit assay as per the manufacturer’s instructions. Libraries were pooled in equimolar 
amounts, denatured, and sequenced on the Illumina NextSeq 500/550 platform using V2 2 × 150 bp chemistry 
with paired-end protocol. Alternatively, sequencing was undertaken using an Illumina HiSeq 2500 system to 
produce 100 bp paired-end sequence fragments (Illumina, Cambridge, United Kingdom). Genome sequencing 
was performed at a minimum average depth of 30 ×. All nucleotide sequences were deposited at DDBJ/EMBL/
GenBank under accession number ERA1598958.
Bioinformatics. Bioinformatic analyses were performed using tools accessed via the MRC Cloud 
Infrastructure for Microbial Bioinformatics (MRC CLIMB) platform, the University of East Anglia Norwich 
High performance cluster (UEA-HPC) or local platforms as appropriate. FASTQ paired-end reads were quality 
trimmed using Trimmomatic 0.36, removing adaptors and low quality or N bases from the leading and trailing 
30 bp. The read was scanned with a 4-base sliding window and cut when the average quality per base dropped 
below 15. If the read length post trimming was less than 36 bp, the read and its pair were discarded. MLST deter-
mination was achieved using SRST2 and processed locally or on the Galaxy computational biology platform. 
SRST2 was also used for E. coli serotype prediction and virulence factor genotyping. While short read serotyping 
analysis employed the EcOH database, Escherichia virulence gene sequences were obtained from the Virulence 
Factors of Bacterial Pathogens database (VFDB; http://www.mgc.ac.cn/cgi-bin/VFs/genus.cgi?Genus=Escheri-
chia) with sequences added from NCBI GenBank as required and pre-clustered with cd-hit at 90% identity.
Statistics. Statistical analysis was performed using GraphPad Prism software (version 6). A P-value of <0.05 
was considered significant.
Data sharing. All data generated or analysed during this study are included in this published article (and 
its Supplementary Information files). All nucleotide sequences were deposited at DDBJ/EMBL/GenBank under 
accession number ERA1598958.
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